Article
Feasibility of Fecal MicroRNAs as Novel Biomarkers for Pancreatic Cancer
8 Aug 2012
Abstract excerpt
INTRODUCTION: Pancreatic cancer (PCA) is an aggressive tumor that associates with high mortality rates. Majority of PCA patients are diagnosed usually at late tumor stages when the therapeutic options are limited. MicroRNAs (miRNA) are involved in tumor development and are commonly dysregulated in PCA. As a proof-of-principle study, we aimed to evaluate the potential of fecal miRNAs as biomarkers for pancreatic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
